Induction of resistance to oxaliplatin in cancer by a microRNA/Fem1B/Gli1 pathway.

Yichen Su(China Medical University), Peter Kaiser(UC Irvine Health)
PubMed
January 1, 2023
Cited by 4


Related Papers